Our website uses its own and third parties cookies for a high level of user-friendliness. If you continue to browse and  use this website we will assume that you agree with the policies.

COVID-19

COVID-19

  • Covid-19 Tests
  • Companies
  • Individuals
  • Online consultations Covid-19

Atrys

Private area

  • Español
  • English

Main navigation

  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • Smart Data
  • R&D
    • R&D
    • LIQUID BIOPSY
    • PROGNOSTIC ALGORITHMS
    • DATA INTEGRATION PLATFORMS
    • ONLINE DIAGNOSIS
    • OTHER PROJECTS
    • R&D services and training agreements
    • Publications and patents
  • Investors
  • News
  • Contact
    • Work with us
  • Español
  • English
  • Company
    • Presentation
    • Mission, vision and values
  • Laboratory
    • Laboratory
    • Test directory
      • Anatomic Pathology
      • Cytology
      • Hematology
      • Diagnostic Second Opinion
    • Clinical trials and R&D services
    • Quality
    • Team
  • Telemedecine
    • What is telemedicine?
    • Radiology
    • Cardiology Cardiology
    • Ophthalmology
    • Dermatology
  • Radiotherapy
  • Smart Data
  • R&D
    • R&D
    • LIQUID BIOPSY
      • BLI-O
      • S100P
      • Surveprost
      • Aptalung
      • InmunoSIGHT
      • Oncoporecise
      • Glibioliquid
      • Metabreast
      • PREDIAPT
      • ONCLIC
    • PROGNOSTIC ALGORITHMS
      • RADIOPROLIQ
      • 3TR
      • Predictgyn
      • Tradion P
      • Anxarecu
      • Precisesads
      • Oncoexpert
      • Prostatepredict
      • IHC and FISH study of EGFRvIII and PTEN expression in relapsed high grade gliomas
      • Identification of a predictive model for therapeutic guidance in cerebral tumors (gliomas) by means of systems pathology
      • Identificación de un modelo predictivo de opción terapéutica en cáncer de mama mediante la aplicación de la Patología Molecular y de Sistemas
      • Identificación de un modelo predictivo de opción terapéutica en linfomas de célula grande (DLBCL) mediante la aplicación de Patología de Sistemas
    • DATA INTEGRATION PLATFORMS
      • Plataforma de ayuda a la detección temprana de enfermedades infecciosas, mediante la identificación local de patógenos a partir de resultados de analíticas provenientes de laboratorios de análisis mediante técnicas de big data y hacking ético
    • ONLINE DIAGNOSIS
      • Daplia
      • eDCardio
      • eDSalud
      • eHealth areas in Hotels
    • OTHER PROJECTS
      • TheraYAP
      • Gliomatherapy
      • Papiloma
      • Zitomab
      • System of pharmacogenomic evaluation for breast cancer treatment with aromatase inhibitors according to a new application designed by ROVI Laboratories
      • CoVIg3
      • RAP-ID19
    • R&D services and training agreements
    • Publications and patents
      • Methods for prognosis of diffuse large b-cell lymphoma
      • EGFR and PTEN gene alterations predicts survival in patients with brain tumors
      • Monoclonal antibodies for the diagnosis, treatment and/or prevention of brain tumors and brain lesions
  • Investors
  • News
  • Contact
    • Work with us

Private area

MAB - Mercado Alternativo Bursátil

Company

  • Presentation
  • Mission, vision and values
  • Presentation
  • Mission, vision and values

Mission, vision and values

Mission

Atrys is born with the mission to help people live healthier lives with a prolonged life expectancy.

To do this, it seeks to facilitate access to medical diagnosis and treatments of excellence, overcoming physical location barriers between doctor and patient specialist.

Vision

Atrys considers that Spain represents an adequate market for initially, and without giving up their internationalization, introducing the clinical model of the Company for the treatment of cancer, due to the relative scarcity of new generation radiotherapy equipment and the almost nonexistent Single Dose Dadiotherapy.

Values

Atrys values are based on four pillars:

  • Excellence in diagnostic services
  • Center of Advanced radio oncology centers to provide customized Single Dose Radiation treatments
  • Own telemedicine platform and international network of medical experts
  • Research and development of new tools for improved diagnosis and treatment

 

  • Presentation
  • Mission, vision and values
  • Presentation
  • Mission, vision and values
Atrys logo

Atrys Madrid

C/ Velázquez 24, 4ºIzq
28001 Madrid

T: +34 917 819 465

info@atryshealth.com

Atrys Barcelona

C/Provença 392, planta baixa, 
08025, Barcelona

T: +34 934 815 561

info@atryshealth.com

Atrys Granada

Edificio Genyo (PTCS)

Av. Ilustración 114 
18007  Granada

T: +34 958 715 500, ext. 125

info@atryshealth.com

Atrys Lugo

ICM/Atrys Division

Parque empresarial As Gándaras

Rúa María Barbeito, 61
27003 Lugo, España

T: +34 982 240 944
T: +34 902 212 054

Atrys Bogotá

Edificio Global Medical Center

Calle 116 No. 9 - 72, Oficina 410
Bogotá - Colombia

T: (571) 675 0195
T: 316 525 9414
T: 317 517 9533

teleradiologiadecolombia.com

Atrys Santiago de Chile

ITMS/Atrys Division

Av. Gertrudis Echeñique 30
Las Condes 71
Santiago de Chile

T: +56 (2) 2 437 49 04

www.itms.cl

Atrys Sao Paulo

AxisMed/Atrys Division

Avenida das Nações Unidas, 13.797
Bloco II - 18 andar
São Paulo – SP- Brasil

T: +55 11 3513 – 2924

www.portalaxismed.com.br

 

 

Web design | Legal advice